We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Vor Biopharma Inc | NASDAQ:VOR | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.1501 | 13.40% | 1.2701 | 1.28 | 1.32 | 1.32 | 1.17 | 1.223 | 1,911,727 | 00:52:42 |
From Nov 2024 to Jan 2025
Stifel 2024 Healthcare Conference Fireside Chat: Monday, November 18, 2024 at 2:25 pm ETLocation: New York, NY
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
1 Year Vor Biopharma Chart |
1 Month Vor Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
